|
|
|
Publicaciones referentes en anemia renal
|
|
|
|
|
|
|
|
- Levin A.
Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR.
Nephrol Dial Transplant. 2007 Feb;22(2):309-12.
Más información
- Bunn H.F.,
New agents that stimulate erythropoiesis Blood. 2007 Feb 1;109(3):868-73
Más información
- Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A; CREATE Investigators.
Normalization of hemoglobin level in patients with chronic kidney disease and anemia.
N Engl J Med. 2006 Nov 16;355(20):2071-84. Comment in: N Engl J Med. 2006 Nov 16;355(20):2144-6.
Más información
- Remuzzi G, Ingelfinger JR.
Correction of anemia--payoffs and problems. N Engl J Med. 2006 Nov 16;355(20):2144-6.
Más información
- Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D; CHOIR Investigators.
Correction of anemia with epoetin alfa in chronic kidney disease.N Engl J Med. 2006 Nov 16;355(20):2085-98.
Comment in: N Engl J Med. 2006 Nov 16;355(20):2144-6.
Más información
- Macdougall IC, Eckardt KU.
Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia.
Lancet. 2006 Sep 9;368(9539):947-53.
Más información
- Ble A, Fink JC, Woodman RC, Klausner MA, Windham BG, Guralnik JM, Ferrucci L.
Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study.
Arch Intern Med. 2005 Oct 24;165(19):2222-7.
Más información
- Chatterjee PK.
Pleiotropic renal actions of erythropoietin.
Lancet. 2005 May 28-Jun 3;365(9474):1890-2.
Más información
- Maiese K, Li F, Chong ZZ.
New avenues of exploration for erythropoietin.
JAMA. 2005 Jan 5;293(1):90-5.
Más información
- National Kidney Foundation KDOQI;
IV. Clinical practice recommendations for anemia in chronic kidney disease in transplant recipients.
PMID: 16678658 [PubMed - indexed for MEDLINE]
Más información
- Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.
Engl J Med. 1998 Aug 27;339(9):584-90.
Más información
- Rao DS, Shih MS, Mohini R.
Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
N Engl J Med. 1993 Jan 21;328(3):171-5.
Más información
- Erslev AJ.
Erythropoietin.N Engl J Med. 1991 May 9;324(19):1339-44.
Más información
- Nissenson AR, Nimer SD, Wolcott DL.
Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects.
Ann Intern Med. 1991 Mar 1;114(5):402-16.
Más información
- Taylor JE, Henderson IS, Mactier RA, Stewart WK.
Effects of withdrawing erythropoietin. BMJ. 1991 Feb 2;302(6771):272-3.
Más información
- [No authors listed] Canadian Erythropoietin Study Group.
Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis.
BMJ. 1990 Mar 3;300(6724):573-8.
Más información
- Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW.
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin.
Results of a combined phase I and II clinical trial.N Engl J Med. 1987 Jan 8;316(2):73-8.
Más información
|
|
|